Reynolds Cameron John bought VNRX

June 1, 2024 · Form 4 insider transaction

Reynolds Cameron John bought 90,182 shares of VolitionRx Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4.

Direction
Acquired (buy-side)
Shares
90,182
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 1, 2024
Filing dateJune 4, 2024
Shares owned after1,844,850
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On June 1, 2024, the reporting person was awarded 90,182 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 30,061 units, 30,061 units, and 30,060 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

View the original Form 4 on SEC EDGAR